4//SEC Filing
Tierney David S 4
Accession 0001161697-25-000302
CIK 0001369568other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 5:00 PM ET
Size
9.1 KB
Accession
0001161697-25-000302
Insider Transaction Report
Form 4
Tierney David S
Director
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-08-27$20.20/sh−26,000$525,200→ 379,620 total - Exercise/Conversion
Common Stock, par value $0.001 per share
2025-08-27$2.24/sh+50,000$112,000→ 405,620 total - Exercise/Conversion
Options to purchase common stock
2025-08-27−50,000→ 158,274 totalExercise: $2.24Exp: 2025-12-19→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Shares were sold on the open market to fund the exercise price and estimated taxes due from Reporting Person as a result of the exercise of the stock options reported on Table II.
- [F2]Represents a weighted average sales price for the shares sold. Shares were sold in a range from $20.10 to $20.32 per share.
- [F3]Derivative securities vested in three annual tranches beginning on December 19, 2019.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001292636
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 5:00 PM ET
- Size
- 9.1 KB